Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome

ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous, arterial, or small-vessel thrombosis and/or pregnancy-related morbidity, associated with persistent positivity of antiphospholipid antibodies (aPL). Pregnancy-related morbidity in APS patients is characterize...

Full description

Autores:
Cadavid Jaramillo, Angela Patricia
Velásquez Berrio, Manuela
Fierro Martínez, Juan José
de Leeuw, Karina
Tipo de recurso:
Review article
Fecha de publicación:
2022
Institución:
Universidad de Antioquia
Repositorio:
Repositorio UdeA
Idioma:
eng
OAI Identifier:
oai:bibliotecadigital.udea.edu.co:10495/43625
Acceso en línea:
https://hdl.handle.net/10495/43625
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0897
Palabra clave:
Síndrome Antifosfolípido
Antiphospholipid Syndrome
Autoanticuerpos
Autoantibodies
Embarazo
Pregnancy
Pregnancy Complications
Complicaciones del Embarazo
beta 2-Glycoproteína I
beta 2 Glicoprotein I
https://id.nlm.nih.gov/mesh/D016736
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D011247
https://id.nlm.nih.gov/mesh/D011248
https://id.nlm.nih.gov/mesh/D053482
Rights
openAccess
License
http://creativecommons.org/licenses/by-nc-nd/2.5/co/
id UDEA2_9c24455218d70c8fd19e44e6fd6c0b74
oai_identifier_str oai:bibliotecadigital.udea.edu.co:10495/43625
network_acronym_str UDEA2
network_name_str Repositorio UdeA
repository_id_str
dc.title.spa.fl_str_mv Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
title Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
spellingShingle Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
Síndrome Antifosfolípido
Antiphospholipid Syndrome
Autoanticuerpos
Autoantibodies
Embarazo
Pregnancy
Pregnancy Complications
Complicaciones del Embarazo
beta 2-Glycoproteína I
beta 2 Glicoprotein I
https://id.nlm.nih.gov/mesh/D016736
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D011247
https://id.nlm.nih.gov/mesh/D011248
https://id.nlm.nih.gov/mesh/D053482
title_short Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
title_full Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
title_fullStr Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
title_full_unstemmed Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
title_sort Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome
dc.creator.fl_str_mv Cadavid Jaramillo, Angela Patricia
Velásquez Berrio, Manuela
Fierro Martínez, Juan José
de Leeuw, Karina
dc.contributor.author.none.fl_str_mv Cadavid Jaramillo, Angela Patricia
Velásquez Berrio, Manuela
Fierro Martínez, Juan José
de Leeuw, Karina
dc.contributor.researchgroup.spa.fl_str_mv Grupo de Investigación en Trombosis
Grupo Reproducción
dc.subject.decs.none.fl_str_mv Síndrome Antifosfolípido
Antiphospholipid Syndrome
Autoanticuerpos
Autoantibodies
Embarazo
Pregnancy
Pregnancy Complications
Complicaciones del Embarazo
beta 2-Glycoproteína I
beta 2 Glicoprotein I
topic Síndrome Antifosfolípido
Antiphospholipid Syndrome
Autoanticuerpos
Autoantibodies
Embarazo
Pregnancy
Pregnancy Complications
Complicaciones del Embarazo
beta 2-Glycoproteína I
beta 2 Glicoprotein I
https://id.nlm.nih.gov/mesh/D016736
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D011247
https://id.nlm.nih.gov/mesh/D011248
https://id.nlm.nih.gov/mesh/D053482
dc.subject.meshuri.none.fl_str_mv https://id.nlm.nih.gov/mesh/D016736
https://id.nlm.nih.gov/mesh/D001323
https://id.nlm.nih.gov/mesh/D011247
https://id.nlm.nih.gov/mesh/D011248
https://id.nlm.nih.gov/mesh/D053482
description ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous, arterial, or small-vessel thrombosis and/or pregnancy-related morbidity, associated with persistent positivity of antiphospholipid antibodies (aPL). Pregnancy-related morbidity in APS patients is characterized by unexplained fetal deaths, premature birth of morphologically normal newborns, and/or consecutive pregnancy losses before the 10th week of gestation. Beta 2-glycoprotein 1 (ß2GP1) is the main antigen recognized by aPL and plays an essential role in the pathogenesis of APS. Antibodies against ß2GP1 (aß2GP1) are involved in damage-generating mechanisms in APS due to their interaction with trophoblasts, decidua, and endothelial cells. aß2GP1 might be used as a prognostic tool for obstetric risk stratification and ß2GP1 could be a target for molecular-targeted treatment to prevent pregnancy morbidity in APS. This review describes these aspects of aß2GP1, including effects on different cellular targets, its association with the severity of obstetric manifestations and the potential of ß2GP1-targeted therapies for APS.
publishDate 2022
dc.date.issued.none.fl_str_mv 2022
dc.date.accessioned.none.fl_str_mv 2024-11-20T14:23:51Z
dc.date.available.none.fl_str_mv 2024-11-20T14:23:51Z
dc.type.spa.fl_str_mv Artículo de revisión
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_2df8fbb1
dc.type.coar.spa.fl_str_mv http://purl.org/coar/resource_type/c_dcae04bc
dc.type.redcol.spa.fl_str_mv https://purl.org/redcol/resource_type/ARTREV
dc.type.coarversion.spa.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.driver.spa.fl_str_mv info:eu-repo/semantics/article
dc.type.version.spa.fl_str_mv info:eu-repo/semantics/publishedVersion
format http://purl.org/coar/resource_type/c_dcae04bc
status_str publishedVersion
dc.identifier.citation.spa.fl_str_mv Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol. 2022 Jan;87(1):e13509. doi: 10.1111/aji.13509.
dc.identifier.issn.none.fl_str_mv 1046-7408
dc.identifier.uri.none.fl_str_mv https://hdl.handle.net/10495/43625
dc.identifier.doi.none.fl_str_mv 10.1111/aji.13509
dc.identifier.eissn.none.fl_str_mv 1600-0897
dc.identifier.url.spa.fl_str_mv http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0897
identifier_str_mv Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol. 2022 Jan;87(1):e13509. doi: 10.1111/aji.13509.
1046-7408
10.1111/aji.13509
1600-0897
url https://hdl.handle.net/10495/43625
http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0897
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.ispartofjournalabbrev.spa.fl_str_mv Am J Reprod Immunol
dc.relation.citationendpage.spa.fl_str_mv 11
dc.relation.citationissue.spa.fl_str_mv 1
dc.relation.citationstartpage.spa.fl_str_mv 1
dc.relation.citationvolume.spa.fl_str_mv 87
dc.relation.ispartofjournal.spa.fl_str_mv American Journal of Reproductive Immunology
dc.rights.uri.*.fl_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.uri.spa.fl_str_mv https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.rights.accessrights.spa.fl_str_mv info:eu-repo/semantics/openAccess
dc.rights.coar.spa.fl_str_mv http://purl.org/coar/access_right/c_abf2
rights_invalid_str_mv http://creativecommons.org/licenses/by-nc-nd/2.5/co/
https://creativecommons.org/licenses/by-nc-nd/4.0/
http://purl.org/coar/access_right/c_abf2
eu_rights_str_mv openAccess
dc.format.extent.spa.fl_str_mv 11 páginas
dc.format.mimetype.spa.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Wiley-Blackwell
dc.publisher.place.spa.fl_str_mv Copenhague, Dinamarca
institution Universidad de Antioquia
bitstream.url.fl_str_mv https://bibliotecadigital.udea.edu.co/bitstreams/bfb0dc8e-b9f5-4885-a258-2bc826217869/download
https://bibliotecadigital.udea.edu.co/bitstreams/fdf33849-52df-4fc5-8da9-2357fa821e38/download
https://bibliotecadigital.udea.edu.co/bitstreams/e96b7fd9-2b2a-4df0-a21c-df6093ef50c1/download
https://bibliotecadigital.udea.edu.co/bitstreams/61c8a9a4-fafc-446c-937b-ddf1cffd50c8/download
https://bibliotecadigital.udea.edu.co/bitstreams/79a0d2d5-fd1b-40df-89c6-6a594d2f936a/download
bitstream.checksum.fl_str_mv ecb7b1efbb1fd1376b2fabf845afeeb1
b88b088d9957e670ce3b3fbe2eedbc13
8a4605be74aa9ea9d79846c1fba20a33
449f43f3a736a8348a72ec074316f585
e883e3cea682ef274c53a5d75d95ab9c
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
MD5
MD5
repository.name.fl_str_mv Repositorio Institucional de la Universidad de Antioquia
repository.mail.fl_str_mv aplicacionbibliotecadigitalbiblioteca@udea.edu.co
_version_ 1851052449471660032
spelling Cadavid Jaramillo, Angela PatriciaVelásquez Berrio, ManuelaFierro Martínez, Juan Joséde Leeuw, KarinaGrupo de Investigación en TrombosisGrupo Reproducción2024-11-20T14:23:51Z2024-11-20T14:23:51Z2022Fierro JJ, Velásquez M, Cadavid AP, de Leeuw K. Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndrome. Am J Reprod Immunol. 2022 Jan;87(1):e13509. doi: 10.1111/aji.13509.1046-7408https://hdl.handle.net/10495/4362510.1111/aji.135091600-0897http://onlinelibrary.wiley.com/journal/10.1111/(ISSN)1600-0897ABSTRACT: Antiphospholipid syndrome (APS) is an autoimmune disease characterized by venous, arterial, or small-vessel thrombosis and/or pregnancy-related morbidity, associated with persistent positivity of antiphospholipid antibodies (aPL). Pregnancy-related morbidity in APS patients is characterized by unexplained fetal deaths, premature birth of morphologically normal newborns, and/or consecutive pregnancy losses before the 10th week of gestation. Beta 2-glycoprotein 1 (ß2GP1) is the main antigen recognized by aPL and plays an essential role in the pathogenesis of APS. Antibodies against ß2GP1 (aß2GP1) are involved in damage-generating mechanisms in APS due to their interaction with trophoblasts, decidua, and endothelial cells. aß2GP1 might be used as a prognostic tool for obstetric risk stratification and ß2GP1 could be a target for molecular-targeted treatment to prevent pregnancy morbidity in APS. This review describes these aspects of aß2GP1, including effects on different cellular targets, its association with the severity of obstetric manifestations and the potential of ß2GP1-targeted therapies for APS.Colombia. Ministerio de Ciencia, Tecnología e Innovación - MinCienciasCOL0010421COL000763111 páginasapplication/pdfengWiley-BlackwellCopenhague, Dinamarcahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/https://creativecommons.org/licenses/by-nc-nd/4.0/info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Effects of anti-beta 2-glycoprotein 1 antibodies and its association with pregnancy-related morbidity in antiphospholipid syndromeArtículo de revisiónhttp://purl.org/coar/resource_type/c_dcae04bchttp://purl.org/coar/resource_type/c_2df8fbb1https://purl.org/redcol/resource_type/ARTREVhttp://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionSíndrome AntifosfolípidoAntiphospholipid SyndromeAutoanticuerposAutoantibodiesEmbarazoPregnancyPregnancy ComplicationsComplicaciones del Embarazobeta 2-Glycoproteína Ibeta 2 Glicoprotein Ihttps://id.nlm.nih.gov/mesh/D016736https://id.nlm.nih.gov/mesh/D001323https://id.nlm.nih.gov/mesh/D011247https://id.nlm.nih.gov/mesh/D011248https://id.nlm.nih.gov/mesh/D053482Am J Reprod Immunol111187American Journal of Reproductive Immunology1115800762949930-2019757-2016RoR:03fd5ne08PublicationORIGINALCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdfCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdfapplication/pdf787906https://bibliotecadigital.udea.edu.co/bitstreams/bfb0dc8e-b9f5-4885-a258-2bc826217869/downloadecb7b1efbb1fd1376b2fabf845afeeb1MD51trueAnonymousREADCC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8823https://bibliotecadigital.udea.edu.co/bitstreams/fdf33849-52df-4fc5-8da9-2357fa821e38/downloadb88b088d9957e670ce3b3fbe2eedbc13MD52falseAnonymousREADLICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://bibliotecadigital.udea.edu.co/bitstreams/e96b7fd9-2b2a-4df0-a21c-df6093ef50c1/download8a4605be74aa9ea9d79846c1fba20a33MD53falseAnonymousREADTEXTCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdf.txtCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdf.txtExtracted texttext/plain69422https://bibliotecadigital.udea.edu.co/bitstreams/61c8a9a4-fafc-446c-937b-ddf1cffd50c8/download449f43f3a736a8348a72ec074316f585MD54falseAnonymousREADTHUMBNAILCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdf.jpgCadavidAngela_2021_Effects_Anti-beta2_Glycopretein1.pdf.jpgGenerated Thumbnailimage/jpeg15989https://bibliotecadigital.udea.edu.co/bitstreams/79a0d2d5-fd1b-40df-89c6-6a594d2f936a/downloade883e3cea682ef274c53a5d75d95ab9cMD55falseAnonymousREAD10495/43625oai:bibliotecadigital.udea.edu.co:10495/436252025-03-26 22:31:39.287http://creativecommons.org/licenses/by-nc-nd/2.5/co/open.accesshttps://bibliotecadigital.udea.edu.coRepositorio Institucional de la Universidad de Antioquiaaplicacionbibliotecadigitalbiblioteca@udea.edu.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